DNA Capital’s R$300 Million Investment in Memed

Bronstein, Zilberberg, Chueiri & Potenza Advogados represented Memed in the transaction.

Memed, national leader in digital medical prescriptions, has agreed a contribution of 300 million reais through a fund structured by DNA Capital.

DNA Capital is an investment partnership specializing in multi-stage investments in the healthcare sector, ranging from early stage companies to private equity.

Bronstein, Zilberberg, Chueiri & Potenza Advogados advised Memed with a team led by partner Eduardo Zilberberg (Picture), with partner Vivian Rudge and associates Beatriz Angelo and Fabio Baum.

Involved fees earner: Beatriz Angelo – Bronstein, Zilberberg, Chueiri & Potenza Advogados; Fabio Baum – Bronstein, Zilberberg, Chueiri & Potenza Advogados; Vivian Tito Rudge – Bronstein, Zilberberg, Chueiri & Potenza Advogados; Eduardo Zilberberg – Bronstein, Zilberberg, Chueiri & Potenza Advogados;

Law Firms: Bronstein, Zilberberg, Chueiri & Potenza Advogados;

Clients: Memed;